drug

ARGX-121

2 stories · latest Aug 27, 2026

Timeline

argenx completes acquisition of Forte Biosciences

Aug 27M&Aargenx

argenx registers Phase 2 trial of ARGX-121 in IgA nephropathy

Aug 19Trial updateargenx ARGX-121